The Changing Face of Biomedical Research in Tuberculosis

References 

1. Kappelman J , et al.   First Homo erectus from Turkey and implications for migrations into temperate Eurasia . Am. J. Phys. Anthropol. . 2008;135:110–116
   • CrossRef
2. World Health Organization. 2007. Global tuberculosis control – surveillance, planning, financing. WHO Report 2008. WHO/HTM/TB/2008.3393, Annex 3.1: Estimated burden of TB, 1990 and 2006. (http://www.who.int/tb/publications/global_report/2008/en/index.html; http://www.who.int/tb/publications/global_report/2008/xls/annex3_global.xls)
3. Stop TB Partnership and World Health Organization. 2006. The global plan to stop TB 2006-2015. WHO/HTM/STB/2006.35. (http://www.stoptb.org/globalplan/assets/documents/GlobalPlanFinal.pdf)
4. World Health Organization. 2005. Addressing poverty in TB control – options for national TB control programmes. WHO/HTM/TB/2005. 352. (http://whqlibdoc.who.int/hq/2005/WHO_HTM_TB_2005.352.pdf)
5. Laxminarayan R , et al.   Economic benefit of tuberculosis control. The World Bank Policy Research Working Paper 4295 . http://www.who.int/tb/features_archive/wb_who_press_13dec07/en/index.html 2007;
6. Feuer C . Tuberculosis research and development: a critical analysis of funding trends, 2005-2006 . http://www.aidsinfonyc.org/tag/tbhiv/tbrandd/2007tbranddreport.pdf 2007;
7. Centers for Disease Control and Prevention  . Outbreak of multidrug-resistant tuberculosis at a hospital – New York City, 1991 . Morb. Mortal. Wkly. Rep. . 1993;42:433–434 427
8. Petersen LR , Hayes EB . Westward ho? – The spread of West Nile virus . N. Engl. J. Med. . 2004;351:2257–2259
   • CrossRef
9. National Institute of Allergy and Infectious Diseases  . The NIAID research agenda for emerging infectious diseases . http://www.niaid.nih.gov/publications/execsum/contents.htm
10. Schneider E , Moore M , Castro KG . Epidemiology of tuberculosis in the United States . Clin. Chest Med. . 2005;26:183–195
    • Abstract
    • Full Text
    • Full-Text PDF (262 KB)
    • CrossRef
11. National Institute of Allergy and Infectious Diseases  . NIAID global health research plan for HIV/AIDS, malaria and tuberculosis . www.niaid.nih.gov/publications/globalhealth/global.pdf
12. Clark-Curtiss JE , Haydel SE . Molecular genetics of Mycobacterium tuberculosis pathogenesis . Annu. Rev Microbiol. . 2003;57:517–549
    • MEDLINE
    • CrossRef
13. Dannenberg AM , Collins FM . Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products . Tuberculosis . 2001;81:229–242
14. Bhatt K , Salgame P . Host innate immune response to Mycobacterium tuberculosis . J. Clin. Immunol. . 2007;27:347–362
    • MEDLINE
    • CrossRef
15. Palomino JC . Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis . Curr. Opin. Pulm. Med. . 2006;12:172–178
    • MEDLINE
16. Cole ST . Comparative mycobacterial genomics as a tool for drug target and antigen discovery . Eur. Respir. J. . 2002;36(Suppl):S78–S86
17. Matteelli A , et al.   Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control . Expert Rev. Anti. Infect. Ther. . 2007;5:857–871
18. Shah NS . Worldwide emergence of extensively drug-resistant tuberculosis . Emerg. Infect. Dis. . 2007;13:380–387
    • MEDLINE
19. Friedland G . Tuberculosis, drug resistance, and HIV/AIDS: a triple threat . Curr. Infect. Dis. Rep. . 2007;9:252–261
20. Gandhi NR , et al.   Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa . Lancet . 2006;368:1575–1580
    • Abstract
    • Full Text
    • Full-Text PDF (108 KB)
    • CrossRef